Bioresorbable membrane to reduce postoperative small bowel obstruction in patients with gastric cancer: A randomized clinical trial

Annals of Surgery

Volumn 247, Issue 5, 2008, Pages 766-770

  Hayashi, Shigeoki ^a   Takayama, Tadatoshi ^a   Masuda, Hideki ^a   Kochi, Mitsugu ^a   Ishii, Yukimoto ^a   Matsuda, Minoru ^a   Yamagata, Motoo ^a   Fujii, Masashi ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID;

ABDOMINAL INJURY; ABDOMINAL SURGERY; ADULT; AGED; ARTICLE; CANCER SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEMBRANE; MORBIDITY; MORTALITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPRAFILM; SMALL INTESTINE; SMALL INTESTINE OBSTRUCTION; STOMACH CANCER;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; HYALURONIC ACID; INCIDENCE; INTESTINAL OBSTRUCTION; INTESTINE, SMALL; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; SINGLE-BLIND METHOD; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 42549112979     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181656d4e     Document Type: Article

References (20)

1. Vrijland WW, Tseng LN, Eijkman HM, et al. Fewer intraperitoneal adhesions with use of hyaluronic acid-carboxymethylcellulose membrane: a randomized clinical trial. Ann Surg. 2002;235:193-199.
2. Becker JM, Dayton MT, Fazio VW, et al. Prevention of postoperative abdominal adhesions by a sodium hyaluronate-based bioresorbable membrane: a prospective, randomized, double-blind multicenter study. J Am Coll Surg. 1996;183:297-306.
3. Diamond MP. Reduction of adhesions after uterine myomectomy by Seprafilm membrane (HAL-F): a blinded, prospective, randomized, multicenter clinical study. Fertil Steril. 1996;66:904-910.
4. Salum M, Wexner JJ, Nogueras EW, et al. Does sodium hyaluronate- and carboxymethylcellurose-based bioresorbable membrane (Seprafilm) decrease operative time for loop ileostomy closure? Tech Coloproctol. 2006;10:187-191.
5. Kusunoki M, Ikeuchi H, Yanagi H, et al. Bioresorbable hyaluronate-carboxymethylcelluroce membrane (Seprafilm) in surgery for rectal carcinoma: a prospective randomized clinical trial. Surg Today. 2005; 35:940-945.
6. Salum MR, Lam DY, Wexner SD, et al. Does limited placement of bioresorbable membrane of modified sodium hyaluronate and carboxymethylcellulose (Seprafilm) have possible short-term beneficial impact? Dis Colon Rectum. 2001;44:706-712.
7. Oikonomakis I, Wexner SD, Gervaz P, et al. Seprafilm: a retrospective preliminary evaluation of the impact on short-term oncologic outcome in colorectal cancer. Dis Colon Rectum. 2002;45:1376-1380.
8. Mohri Y, Uchida K, Araki T, et al. Hyaluronic acid-carboxycellurose membrane (Seprafilm) reduces early postoperative small bowel obstruction in gastrointestinal surgery. Am Surgeon. 2005;71:861-863.
9. Burns JW, Colt MJ, Burgess LS, et al. Preclinical evaluation of Seprafilm bioresorbable membrane. Eur J Surg Suppl. 1997;577:40-48.
10. Fazio VW, Cohen Z, Fleshman JW, et al. Reduction in adhesive small-bowel obstruction by Seprafilm adhesion barrier after intestinal resection. Dis Colon Rectum. 2006;49:1-11.
11. Inaba T, Okinaga K, Fukushima R, et al. Prospective randomized study of two laparotomy incisions for gastrectomy: midline incision versus transverse incision. Gastric Cancer. 2004;7:167-171.
12. Korenaga D, Yasuda M, Takesue F, et al. Factors influencing the development of small intestinal obstruction following total gastrectomy for gastric cancer: the impact of reconstructive route in the Roux-Y procedure. Hepato-Gastroenterol. 2001;48:1389-1392.
13. Japanese Classification of Gastric Carcinoma - 2nd English Edition - Japanese Gastric Cancer Association. Gastric Cancer. 1998;1:10-24.
14. Schwarz RE, Zagala NK. Recurrence patterns after radical gastrectomy for gastric cancer: prognostic factors and implications for postoperative adjuvant therapy. Ann Surg Oncol. 2002;9:394-400.
15. Angelica MD, Gonen M, Brennan MF, et al. Patterns of initial recurrence in complete resected gastric adenocarcinoma. Ann Surg. 2004;240: 808-816.
16. Beck DE, Cohen Z, Fleshman JW, et al. A prospective, randomized, multicenter, controlled study of the safety of Seprafilm adhesion barrier in abdominopelvic surgery of the intestine. Dis Colon Rectum. 2003;46: 1310-1319.
17. Klingler PJ, Floch NR, Seelig MH, et al. Seprafilm-induced peritoneal inflammation: a previously unknown complication. Dis Colon Rectum. 1999;42:1639-1643.
18. Underwood RA, Wu JS, Wright MP, et al. Sodium hyaluronate carboxymethylcellulose-based bioresorbable membrane (Seprafilm) - dose it affect tumor implantation at abdominal wound site? Dis Colon Rectum. 1999;42:614-618.
19. Hubbard SC, Burns JW. Effect of a hyaluronan-based membrane (Seprafilm) on intraperitoneally disseminated human colon cancer cell growth in a nude mouse model. Dis Colon Rectun. 2002;45:334-344.
20. Adachi Y, Shiraishi N, Shiromizu A, et al. Laparoscopy-assisted Billroth I gastrectomy compared with conventional open gastrectomy. Arch Surg. 2000;135:806-810.